South & Central America Organoids Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

Description

List of Tables

The South and Central America organoids market is projected to grow significantly, reaching approximately US$ 806.23 million by 2031, up from US$ 160.44 million in 2023. This growth represents a compound annual growth rate (CAGR) of 22.4% from 2023 to 2031.

Executive Summary and Market Analysis

The organoids market in South and Central America is divided into key regions: Brazil, Argentina, and the Rest of South and Central America. The market is anticipated to expand due to several factors, including the rising incidence of cancer, increased government initiatives, and enhanced research and development in organoids.

Market Segmentation Analysis

The South and Central America organoids market is categorized based on type, application, source, offering, and method:

Type: The market includes organoids derived from various organs such as the intestine, liver, stomach, pancreas, lung, brain, kidney, and others. In 2023, the intestine organoids segment held the largest market share.
Application: The applications of organoids are segmented into developmental biology disease, infectious disease pathology, regenerative medicine, drug toxicity and efficacy testing, drug discovery, personalized medicine, and others. The developmental biology disease segment was the largest in 2023.
Source: The market is divided into organoids sourced from pluripotent stem cells and organ-specific adult stem cells, with pluripotent stem cells dominating the market share in 2023.
Offering: This segment includes instruments, consumables, and services, with consumables holding the largest share in 2023. The instruments segment is further divided into devices and equipment, while consumables include sensors and other items.
Method: The methods used in organoid development include micropatterned plates, ultralow attachment plates, hanging drop, microdroplet or emulsion, and others. The hanging drop method was the most prominent in 2023.

Market Outlook

Technological advancements are driving the integration of organoids with organ-on-a-chip technologies, enhancing applications in biological and biomedical research, particularly in disease modeling and clinical drug screening. Organoids combined with organ-on-a-chip technologies are transforming cancer research paradigms and offering tangible clinical benefits. The collaborative use of organoids with organ-on-a-chip and 3D bioprinting is paving the way for sophisticated cancer models that investigate tumor-stroma interactions, multiorgan tumor metastasis, and cancer-microenvironment dynamics. The development of organoid-on-a-chip systems, which incorporate multiple organoids on a single chip, is an emerging area with significant potential for studying complex cancer interactions.

Country Insights

The South and Central America organoids market is primarily represented by Brazil, Argentina, and other regions, with Brazil holding the largest market share in 2023. Brazil is notable for its extensive kidney and liver transplant programs, ranking second globally. Despite regional disparities in organ donation and allocation, factors such as public acceptance of organ donation, equitable healthcare systems, supportive government policies, and the presence of dedicated healthcare professionals have contributed to the success of Brazil's transplantation initiatives. As of December 2022, approximately 53,000 organ transplants from deceased donors were performed in Brazil, marking a significant achievement in over two decades. The demand for organoids is further fueled by the need for transplants, as they can be developed from a patient's healthy cells to aid in tissue repair post-transplantation. Ongoing research in Brazil is enhancing organoid development through 3D printing technologies, combining bioengineering techniques with pluripotent stem cell cultivation.

Company Profiles

Key players in the organoids market include STEMCELL Technologies Inc., Molecular Devices, LLC, Hubrecht Organoid Technology, Definigen, Organoid Therapeutics, Thermo Fisher Scientific Inc., Corning Inc., Merck KGaA, InSphero, ACRO Biosystems, Bio-Techne Corp, SUN bioscience SA, ORGANOID SCIENCES Co., Ltd., Crown Bioscience Inc., Sartorius AG, 3D Biotek LLC, Prellis Biologics Inc., 3Dnamics Inc., and Cellesce Ltd. These companies are employing various strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.

Product Code: BMIRE00028764

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. South & Central America Organoids Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Increasing Demand for Tumor Modeling and Biobanking
- 4.1.2 Surging Adoption of Personalized Drugs
4.2 Market Restraints
- 4.2.1 Dearth of Skilled Professionals
4.3 Market Opportunities
- 4.3.1 Focus on Drug Discovery Activities
4.4 Future Trends
- 4.4.1 Combination of Organoids and Organ-on-a-Chip
4.5 Impact of Drivers and Restraints:

5. Organoids Market - South & Central America Analysis

5.1 South & Central America Organoids Market Revenue (US$ Million), 2021-2031
5.2 South & Central America Organoids Market Forecast Analysis

6. South & Central America Organoids Market Analysis - by Type

6.1 Intestine
- 6.1.1 Overview
- 6.1.2 Intestine: South & Central America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.2 Liver
- 6.2.1 Overview
- 6.2.2 Liver: South & Central America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.3 Stomach
- 6.3.1 Overview
- 6.3.2 Stomach: South & Central America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.4 Pancreas
- 6.4.1 Overview
- 6.4.2 Pancreas: South & Central America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.5 Lung
- 6.5.1 Overview
- 6.5.2 Lung: South & Central America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.6 Brain
- 6.6.1 Overview
- 6.6.2 Brain: South & Central America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.7 Kidney
- 6.7.1 Overview
- 6.7.2 Kidney: South & Central America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.8 Others
- 6.8.1 Overview
- 6.8.2 Others: South & Central America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. South & Central America Organoids Market Analysis - by Application

7.1 Developmental Biology Disease
- 7.1.1 Overview
- 7.1.2 Developmental Biology Disease: South & Central America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Pathology of Infectious Disease
- 7.2.1 Overview
- 7.2.2 Pathology of Infectious Disease: South & Central America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Regenerative Medicine
- 7.3.1 Overview
- 7.3.2 Regenerative Medicine: South & Central America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Drug Toxicity and Efficacy Testing
- 7.4.1 Overview
- 7.4.2 Drug Toxicity and Efficacy Testing: South & Central America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Drug Discovery and Personalized Medicine
- 7.5.1 Overview
- 7.5.2 Drug Discovery and Personalized Medicine: South & Central America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: South & Central America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. South & Central America Organoids Market Analysis - by Source

8.1 Pluripotent Stem Cells
- 8.1.1 Overview
- 8.1.2 Pluripotent Stem Cells: South & Central America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Organ-Specific Adult Stem Cell
- 8.2.1 Overview
- 8.2.2 Organ-Specific Adult Stem Cell: South & Central America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. South & Central America Organoids Market Analysis - by Offering

9.1 Instruments
- 9.1.1 Overview
- 9.1.2 Instruments: South & Central America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Consumables
- 9.2.1 Overview
- 9.2.2 Consumables: South & Central America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Services
- 9.3.1 Overview
- 9.3.2 Services: South & Central America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. South & Central America Organoids Market Analysis - by Method

10.1 Micropatterned Plates
- 10.1.1 Overview
- 10.1.2 Micropatterned Plates: South & Central America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.2 Ultralow Attachment Plates
- 10.2.1 Overview
- 10.2.2 Ultralow Attachment Plates: South & Central America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.3 Hanging Drop
- 10.3.1 Overview
- 10.3.2 Hanging Drop: South & Central America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.4 Microdroplet or Emulsion
- 10.4.1 Overview
- 10.4.2 Microdroplet or Emulsion: South & Central America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.5 Others
- 10.5.1 Overview
- 10.5.2 Others: South & Central America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

11. South & Central America Organoids Market - Country Analysis

11.1 South & Central America
- 11.1.1 South & Central America Organoids Market - Revenue and Forecast Analysis - by Country
  - 11.1.1.1 South & Central America Organoids Market - Revenue and Forecast Analysis - by Country
  - 11.1.1.2 Brazil: South & Central America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.1.1.2.1 Brazil: South & Central America Organoids Market Share - by Type
    - 11.1.1.2.2 Brazil: South & Central America Organoids Market Share - by Application
    - 11.1.1.2.3 Brazil: South & Central America Organoids Market Share - by Source
    - 11.1.1.2.4 Brazil: South & Central America Organoids Market Share - by Offering
    - 11.1.1.2.5 Brazil: South & Central America Organoids Market Share - by Instruments
    - 11.1.1.2.6 Brazil: South & Central America Organoids Market Share - by Consumables
    - 11.1.1.2.7 Brazil: South & Central America Organoids Market Share - by Method
  - 11.1.1.3 Argentina: South & Central America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.1.1.3.1 Argentina: South & Central America Organoids Market Share - by Type
    - 11.1.1.3.2 Argentina: South & Central America Organoids Market Share - by Application
    - 11.1.1.3.3 Argentina: South & Central America Organoids Market Share - by Source
    - 11.1.1.3.4 Argentina: South & Central America Organoids Market Share - by Offering
    - 11.1.1.3.5 Argentina: South & Central America Organoids Market Share - by Instruments
    - 11.1.1.3.6 Argentina: South & Central America Organoids Market Share - by Consumables
    - 11.1.1.3.7 Argentina: South & Central America Organoids Market Share - by Method
  - 11.1.1.4 Rest of South & Central America: South & Central America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.1.1.4.1 Rest of South & Central America: South & Central America Organoids Market Share - by Type
    - 11.1.1.4.2 Rest of South & Central America: South & Central America Organoids Market Share - by Application
    - 11.1.1.4.3 Rest of South & Central America: South & Central America Organoids Market Share - by Source
    - 11.1.1.4.4 Rest of South & Central America: South & Central America Organoids Market Share - by Offering
    - 11.1.1.4.5 Rest of South & Central America: South & Central America Organoids Market Share - by Instruments
    - 11.1.1.4.6 Rest of South & Central America: South & Central America Organoids Market Share - by Consumables
    - 11.1.1.4.7 Rest of South & Central America: South & Central America Organoids Market Share - by Method

12. Industry Landscape

12.1 Overview
12.2 Growth Strategies in Organoids Market
12.3 Organic Growth Strategies
- 12.3.1 Overview
12.4 Inorganic Growth Strategies
- 12.4.1 Overview

13. Company Profiles

13.1 STEMCELL Technologies Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Molecular Devices, LLC.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Hubrecht Organoid Technology
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Definigen
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Organoid Therapeutics
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Thermo Fisher Scientific Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Corning Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Merck KGaA
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 InSphero
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 ACRO Biosystems.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 Bio-Techne Corp
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
13.12 SUN bioscience SA
- 13.12.1 Key Facts
- 13.12.2 Business Description
- 13.12.3 Products and Services
- 13.12.4 Financial Overview
- 13.12.5 SWOT Analysis
- 13.12.6 Key Developments
13.13 ORGANOID SCIENCES Co., Ltd.
- 13.13.1 Key Facts
- 13.13.2 Business Description
- 13.13.3 Products and Services
- 13.13.4 Financial Overview
- 13.13.5 SWOT Analysis
- 13.13.6 Key Developments
13.14 Crown Bioscience Inc
- 13.14.1 Key Facts
- 13.14.2 Business Description
- 13.14.3 Products and Services
- 13.14.4 Financial Overview
- 13.14.5 SWOT Analysis
- 13.14.6 Key Developments
13.15 Sartorius AG
- 13.15.1 Key Facts
- 13.15.2 Business Description
- 13.15.3 Products and Services
- 13.15.4 Financial Overview
- 13.15.5 SWOT Analysis
- 13.15.6 Key Developments
13.16 3D Biotek LLC
- 13.16.1 Key Facts
- 13.16.2 Business Description
- 13.16.3 Products and Services
- 13.16.4 Financial Overview
- 13.16.5 SWOT Analysis
- 13.16.6 Key Developments
13.17 Prellis Biologics Inc.
- 13.17.1 Key Facts
- 13.17.2 Business Description
- 13.17.3 Products and Services
- 13.17.4 Financial Overview
- 13.17.5 SWOT Analysis
- 13.17.6 Key Developments
13.18 3Dnamics Inc.
- 13.18.1 Key Facts
- 13.18.2 Business Description
- 13.18.3 Products and Services
- 13.18.4 Financial Overview
- 13.18.5 SWOT Analysis
- 13.18.6 Key Developments
13.19 Cellesce Ltd
- 13.19.1 Key Facts
- 13.19.2 Business Description
- 13.19.3 Products and Services
- 13.19.4 Financial Overview
- 13.19.5 SWOT Analysis
- 13.19.6 Key Developments

14. Appendix

14.1 About The Insight Partners